sessions at a glance - cmt.com.cnpic1.cmt.com.cn/newspic/files/am14-grids-8x10-final.pdf ·...

Sessions at a Glance

Other Events:

PRE-ANNUAL MEETING SEMINARS (Registration Required)

12:30 PM Thursday–11:00 AM FridayHematology for the Oncologist | S105Improving Quality of Cancer Care and Patient Safety for High-Value Oncology Practice | S404Clinical Care in Oncology for the Advanced Practice Provider | S103Genetics and Genomics for the Practicing Clinician | S100aNew Drugs in Oncology | S100bc

1:00 PM 2:00 3:00 4:00 5:00Special Sessions

Breast Cancer

MTP: BRCA Mutation-Associated Breast Cancer: Local and Systemic Treatment Considerations | E451a

ED: Frontiers in Precision Medicine: Practical Application of Genomic Tools in Breast Cancer Management | E Hall D1

ED: 50 Years of Advances in Breast Cancer Treatment: What Have We Learned? Where Are We Going? | E Hall D1

Cancer Genetics

Cancer Prevention/Epidemiology

EXT ED: Celebrating the 50th Anniversary of the Surgeon General’s Report on Tobacco: Renewing Our Commitment to Effective Cancer Treatment and Control | S100a

ED: Updates in Prostate Cancer Risk and Prevention | S504

Central Nervous System Tumors

Poster Highlights Session: Central Nervous System Tumors Display: 1:00 PM-4:00 PM, E354b | Networking with Experts: 3:00 PM-4:00 PM, E354b | Discussion: 4:30 PM-5:45 PM, E450

MTP: Primary Central Nervous System Lymphoma: Past, Present, and Future | E451a

Clinical Trials

Developmental Therapeutics

Poster Highlights Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics Display: 1:00 PM-4:00 PM, E354b | Networking with Experts: 3:00 PM-4:00 PM, E354b | Discussion: 4:30 PM-5:45 PM, E Arie Crown Theater

EXT ED: Immunology for Nonimmunologists | E354a

Ethics

Gastrointestinal (Colorectal) Cancer

ED: 50 Years of Fluorouracil, Radiation, and Surgery: What We’ve Learned, Recent Advances, and How to Treat Patients Today | E Arie Crown Theater

Gastrointestinal (Noncolorectal) Cancer

ED: Update on Clinical Management of Esophagogastric Cancer | E Arie Crown Theater

Genitourinary Cancer

Poster Highlights Session: Genitourinary (Nonprostate) Cancer Display: 1:00 PM-4:00 PM, S102 | Networking with Experts: 3:00 PM-4:00 PM, Outside S101 | Discussion: 4:30 PM-5:45 PM, S100bc

MTP: A New Age of Immunotherapy in Genitourinary Tumors? | E451a

Geriatric Oncology ED: Preparing for an Epidemic: Cancer Care in an Aging Population | E253

ED: Personalizing Therapy for Elderly Patients with Lymphoid Malignancies | E253

ED: Why Functional Age Matters: Care for Older Patients with Prostate and Bladder Cancer | E253

Gynecologic Cancer

Head and Neck Cancer ED: Value Assessment of Therapeutic Options in Head and Neck Cancer Care | E450

ED: Head and Neck Cancer: The Best of the Rest | E450

Health Services Research

EXT ED: Can We Find Common Ground? Stakeholder Perspectives on Value in Cancer Care | S100a

Leukemia, Myelodysplasia, and Transplantation

Lung Cancer

ED: 50 Years of Lung Cancer: The Current Status of Therapy for Non-Small Cell Lung Cancer—Adjuvant Therapy, Chemoradiotherapy, and Systemic Treatment | E Hall D1

Lymphoma and Plasma Cell Disorders

Poster Highlights Session: Lymphoma and Plasma Cell Disorders Display: 1:00 PM-4:00 PM, S405 | Networking with Experts: 3:00 PM-4:00 PM, Between S405 and S406 | Discussion: 4:30 PM-5:45 PM, S406

Melanoma/Skin Cancers

Patient and Survivor Care EXT ED: Fertility Preservation: State of the Art and Future Directions | S504

Pediatric Oncology

Practice Management and Information Technology

Professional Development

EXT ED: On the Shoulders of Giants: Prostate Cancer Therapy—How We Got Here and Where We Are Going | S406 EXT ED: Why I Love the Career I Chose | S404

EXT ED: Maintenance of Certification and Lifelong Learning Workshop | E451b

EXT ED: Grant Writing Workshop | S103

ED: Special Session for Program Directors and Key Clinical Faculty: Intragenerational Learning—Teaching Millennial Learners and Practical Use of Milestones | E350

Sarcoma

Tumor Biology EXT ED: Tumor Genomic Profiling and the Application to Personalized Medicine: Looking to the Future | S100bc

ED: From Signaling Pathways to Therapeutics: What Are the Targets? | E354a

Friday, May 30CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session SPS = Special Session

MTP = Meet the Professor Session (ticketed) CPO = Clinical Problems in Oncology Session (ticketed) = 50th Anniversary Session

Saturday, May 31 CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session

7:30 AM 8:00 9:00 10:00 11:00 12:00 PM 1:00 2:00 3:00 4:00 5:00

Special SessionsOpening Session with Fellows of the American Society of Clinical Oncology, Guest Speaker’s Address, Presidential Address, ASCO Humanitarian Award, and David A. Karnofsky Memorial Award and Lecture | N Hall B1

Pediatric Oncology Award and Lecture | S504ASCO/American Association for Cancer Research (AACR) Joint Session: Inflammatory Cells and Cancer | S100a

B. J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology | S100a

Breast Cancer

CPO: Breast Cancer Central Nervous System Metastases: A Strategic Approach to Integrating Local and Systemic Therapies | E451b

CSS: Harnessing Biology and Immunology to Develop Novel Biomarkers | N Hall B1 Oral Abstract Session: Breast Cancer—HER2/ER | N Hall B1

Cancer GeneticsCancer Prevention/Epidemiology

ED: Progress in Prevention and Opportunities for the Future | S100bc Oral Abstract Session: Cancer Prevention/Epidemiology | S100bc


CSS: Incorporating Advanced MR and PET Imaging in the Clinic: Are We Ready? | E450 General Poster Session: Central Nervous System Tumors | S Hall A

ED: Radiotherapy for Central Nervous System Tumors: Harnessing Radioactivity from Curie to Cure | E450

Clinical Trials ED: The Changing Landscape of Federally Sponsored Trials | S100a

ED: Practical Considerations in the Design of Clinical Trials of Targeted Therapies and Immunotherapy | S100a


CSS: Emerging Combination Strategies | E Arie Crown Theater

Oral Abstract Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics | E Hall D2

ED: Companion Diagnostics and Biomarker Development in Oncology Drug Development | S100bc

CPO: Optimizing the Use of New Targeted Therapies in the Face of Toxicity | E451b

EthicsED: The Value of Cancer Care, and the Professional and Ethical Obligations of the Practicing Oncologist: A Debate | E253

ED: Tumor Genomic Profiling in Cancer Care: Field of Dreams or Ethical Minefield? | E253


General Poster Session: Gastrointestinal (Colorectal) Cancer | S Hall A Poster Highlights Session: Gastrointestinal (Colorectal) Cancer Display: 1:15 PM-4:15 PM, E354b | Networking with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E Hall D2ED: The Nuts and Bolts of Liver-Directed Therapies: How Are Procedures Done, What Are the Side Effects, and What Are the Data? | E Hall D1

CPO: Treatment of Elderly Patients with Complications Related to Colorectal Cancer | E451b


General Poster Session: Gastrointestinal (Noncolorectal) Cancer | S Hall A

Genitourinary CancerED: Beyond Stage I Germ Cell Tumors | E Hall D2 Poster Highlights Session: Genitourinary (Prostate) Cancer

Display: 1:15 PM-4:15 PM, E354b | Networking with Experts: 3:15 PM-4:15 PM, E354b | Discussion Time: 4:45 PM-6:00 PM, E Arie Crown TheaterCSS: Unleashing the Immune System in Genitourinary Cancers | E Arie Crown Theater

Geriatric Oncology SPS: Developing a Geriatric Oncology Presence at Your Academic Institution or Community-Based Practice | S103 CSS: Outcomes and Interventions in Older Cancer Patients and Survivors | E253

Gynecologic Cancer

MTP: The Best Therapy for a Newly Diagnosed Patient with Advanced-Stage Ovarian Cancer | E451a

Oral Abstract Session: Gynecologic Cancer | E354aED: Selecting the Best Therapy for Recurrent Ovarian Cancer: Progress in Response Prediction over the Last 50 Years | E354a

General Poster Session: Gynecologic Cancer | S Hall A

Head and Neck Cancer

MTP: Intermediate Risk of Head and Neck Squamous Cell Carcinoma | E451a

General Poster Session: Head and Neck Cancer | S Hall AHealth Services Research


ED: Management of Acute Myeloid Leukemia in the Genomic Era | E354a

Poster Highlights Session: Leukemia, Myelodysplasia, and Transplantation Display: 1:15 PM-4:15 PM, S405 | Networking with Experts: 3:15 PM-4:15 PM, Between S405 and S406 | Discussion: 4:45 PM-6:00 PM, S406

ED: Clinical Utility of Genetic Profiling in Myeloid Malignancies | E450

Lung Cancer

CSS: Targeting EGFR: The Next 10 Years | E Hall D1 General Poster Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers | S Hall AGeneral Poster Session: Lung Cancer—Non-Small Cell Metastatic | S Hall A

MTP: Management of Oligometastatic Disease and Oligoprogression of Non-Small Cell Lung Cancer | E451a

ED: Management and Future Directions in Non-Small Cell Lung Cancer with Known Activating Mutations | E Hall D1


CSS: Targeted Therapies in Early, Mid, and Late Development | E Arie Crown Theater

MTP: Challenging Cases in T-Cell Lymphoma | E451a

Melanoma/Skin Cancers General Poster Session: Melanoma/Skin Cancers | S Hall A

ED: Frontline Approach to Metastatic BRAF Mutant Melanoma: Diagnosis, Molecular Evaluation, and Treatment Choice | S406

ED: From Coley to Cure? Past, Present, and Future of Immunotherapy for Melanoma | S406

Patient and Survivor Care

Pediatric Oncology ED: The BRAF Pathway: An Emerging Therapeutic Target in Childhood Cancer | S504 Oral Abstract Session: Pediatric Oncology I | S504


CSS: Optimizing Access to Clinical Trials in Community Practice | E253

ED: Electronic Health Records and How to Optimize Their Use | S404

ED: Community Oncology Town Hall: Ongoing and Future Issues for Practice | S404


ED: How to Navigate the Annual Meeting (Fellows and Junior Faculty Only) | S501

ED: Integrative Oncology: The Evidence Base | S404

ED: Burnout in Health Care Professionals: Improving the Care You Provide by Caring for Your Mental and Physical Well-being | E450

ED: MOC Open Forum: Understanding the Changes | E350

ED: Health Care in America in 2014: Current and Future Implications of the Patient Protection and Affordable Care Act | S404

SarcomaTumor Biology CSS: Advances in Tumor Biology | S406 General Poster Session: Tumor Biology | S Hall A

SPS = Special Session MTP = Meet the Professor Session (ticketed)

CPO = Clinical Problems in Oncology Session (ticketed)

= 50th Anniversary Session

7:30 AM 8:00 9:00 10:00 11:00 12:00 PM 1:00 2:00 3:00 4:00 5:00

Special SessionsOpening Session with Fellows of the American Society of Clinical Oncology, Guest Speaker’s Address, Presidential Address, ASCO Humanitarian Award, and David A. Karnofsky Memorial Award and Lecture | N Hall B1

Pediatric Oncology Award and Lecture | S504ASCO/American Association for Cancer Research (AACR) Joint Session: Inflammatory Cells and Cancer | S100a

B. J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology | S100a

Breast Cancer

CPO: Breast Cancer Central Nervous System Metastases: A Strategic Approach to Integrating Local and Systemic Therapies | E451b

CSS: Harnessing Biology and Immunology to Develop Novel Biomarkers | N Hall B1 Oral Abstract Session: Breast Cancer—HER2/ER | N Hall B1

Cancer GeneticsCancer Prevention/Epidemiology

ED: Progress in Prevention and Opportunities for the Future | S100bc Oral Abstract Session: Cancer Prevention/Epidemiology | S100bc


CSS: Incorporating Advanced MR and PET Imaging in the Clinic: Are We Ready? | E450 General Poster Session: Central Nervous System Tumors | S Hall A

ED: Radiotherapy for Central Nervous System Tumors: Harnessing Radioactivity from Curie to Cure | E450

Clinical Trials ED: The Changing Landscape of Federally Sponsored Trials | S100a

ED: Practical Considerations in the Design of Clinical Trials of Targeted Therapies and Immunotherapy | S100a


CSS: Emerging Combination Strategies | E Arie Crown Theater

Oral Abstract Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics | E Hall D2

ED: Companion Diagnostics and Biomarker Development in Oncology Drug Development | S100bc

CPO: Optimizing the Use of New Targeted Therapies in the Face of Toxicity | E451b

EthicsED: The Value of Cancer Care, and the Professional and Ethical Obligations of the Practicing Oncologist: A Debate | E253

ED: Tumor Genomic Profiling in Cancer Care: Field of Dreams or Ethical Minefield? | E253


General Poster Session: Gastrointestinal (Colorectal) Cancer | S Hall A Poster Highlights Session: Gastrointestinal (Colorectal) Cancer Display: 1:15 PM-4:15 PM, E354b | Networking with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E Hall D2ED: The Nuts and Bolts of Liver-Directed Therapies: How Are Procedures Done, What Are the Side Effects, and What Are the Data? | E Hall D1

CPO: Treatment of Elderly Patients with Complications Related to Colorectal Cancer | E451b


General Poster Session: Gastrointestinal (Noncolorectal) Cancer | S Hall A

Genitourinary CancerED: Beyond Stage I Germ Cell Tumors | E Hall D2 Poster Highlights Session: Genitourinary (Prostate) Cancer

Display: 1:15 PM-4:15 PM, E354b | Networking with Experts: 3:15 PM-4:15 PM, E354b | Discussion Time: 4:45 PM-6:00 PM, E Arie Crown TheaterCSS: Unleashing the Immune System in Genitourinary Cancers | E Arie Crown Theater

Geriatric Oncology SPS: Developing a Geriatric Oncology Presence at Your Academic Institution or Community-Based Practice | S103 CSS: Outcomes and Interventions in Older Cancer Patients and Survivors | E253

Gynecologic Cancer

MTP: The Best Therapy for a Newly Diagnosed Patient with Advanced-Stage Ovarian Cancer | E451a

Oral Abstract Session: Gynecologic Cancer | E354aED: Selecting the Best Therapy for Recurrent Ovarian Cancer: Progress in Response Prediction over the Last 50 Years | E354a

General Poster Session: Gynecologic Cancer | S Hall A


MTP: Intermediate Risk of Head and Neck Squamous Cell Carcinoma | E451a

General Poster Session: Head and Neck Cancer | S Hall AHealth Services Research


ED: Management of Acute Myeloid Leukemia in the Genomic Era | E354a

Poster Highlights Session: Leukemia, Myelodysplasia, and Transplantation Display: 1:15 PM-4:15 PM, S405 | Networking with Experts: 3:15 PM-4:15 PM, Between S405 and S406 | Discussion: 4:45 PM-6:00 PM, S406

ED: Clinical Utility of Genetic Profiling in Myeloid Malignancies | E450

Lung Cancer

CSS: Targeting EGFR: The Next 10 Years | E Hall D1 General Poster Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers | S Hall AGeneral Poster Session: Lung Cancer—Non-Small Cell Metastatic | S Hall A

MTP: Management of Oligometastatic Disease and Oligoprogression of Non-Small Cell Lung Cancer | E451a

ED: Management and Future Directions in Non-Small Cell Lung Cancer with Known Activating Mutations | E Hall D1


CSS: Targeted Therapies in Early, Mid, and Late Development | E Arie Crown Theater

MTP: Challenging Cases in T-Cell Lymphoma | E451a

Melanoma/Skin Cancers General Poster Session: Melanoma/Skin Cancers | S Hall A

ED: Frontline Approach to Metastatic BRAF Mutant Melanoma: Diagnosis, Molecular Evaluation, and Treatment Choice | S406

ED: From Coley to Cure? Past, Present, and Future of Immunotherapy for Melanoma | S406


Pediatric Oncology ED: The BRAF Pathway: An Emerging Therapeutic Target in Childhood Cancer | S504 Oral Abstract Session: Pediatric Oncology I | S504


CSS: Optimizing Access to Clinical Trials in Community Practice | E253

ED: Electronic Health Records and How to Optimize Their Use | S404

ED: Community Oncology Town Hall: Ongoing and Future Issues for Practice | S404


ED: How to Navigate the Annual Meeting (Fellows and Junior Faculty Only) | S501

ED: Integrative Oncology: The Evidence Base | S404

ED: Burnout in Health Care Professionals: Improving the Care You Provide by Caring for Your Mental and Physical Well-being | E450

ED: MOC Open Forum: Understanding the Changes | E350

ED: Health Care in America in 2014: Current and Future Implications of the Patient Protection and Affordable Care Act | S404

SarcomaTumor Biology CSS: Advances in Tumor Biology | S406 General Poster Session: Tumor Biology | S Hall A

Sunday, June 1 CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session

7:30 AM 8:00 9:00 10:00 11:00 12:00 PM 1:00 2:00 3:00 4:00 5:00

Special Sessions

Highlights of the Day I Session Including Clinical Trials Participation Awards | E Hall D1

Plenary Session Including the Science of Oncology Award and Lecture | N Hall B1Plenary Session Simulcast, E Hall D1

Post-Plenary Discussion I: Genitourinary Cancer | S100bc

Post-Plenary Discussion III: Breast Cancer | S100bc

ASCO–American Cancer Society Award and Lecture | S100a

Post-Plenary Discussion II: Gastrointestinal Cancer | S100a

Breast CancerPoster Highlights Session: Breast Cancer—HER2/ER Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00AM, E354b | Discussion: 11:30 AM-12:45 PM, E Arie Crown Theater

ED: Streamlining Breast Cancer Care: Opportunities and Challenges | N Hall B1

Cancer Genetics


General Poster Session: Cancer Prevention/Epidemiology | S Hall AED: Hype versus Hope: Repurposing Metformin, Vitamin D, Aspirin, Beta-Blockers, and Folic Acid for Cancer | S404


Oral Abstract Session: Central Nervous System Tumors | E450ED: Tools for the Best Outcomes in the Management of Brain Metastases | E450

ED: Immunotherapy: Transforming Frustration to Cure in the Next 50 Years | E450

Clinical TrialsED: Access to Data from Clinical Trials: A New Age of Clinical Trial Transparency | S100bc

ED: 50 Years of Precision Medicine: Advances in the Field and Prospective and Innovative Randomized Clinical Trials | S100bc

ED: Developing a Usable Biomarker: Odyssey of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma— From a Journal Report to a Multinational Clinical Trial | S100a


General Poster Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics | S Hall A

General Poster Session: Developmental Therapeutics— Immunotherapy | S Hall A

ED: Radiopharmaceuticals: Spanning Hematologic Malignancies to Solid Tumors | S100a

EthicsED: Eight Days a Week: Managing Cumulative Expectations for the Busy Oncology Provider | E253


ED: The Evolution of Our Molecular Understanding of Colorectal Cancer: What We Are Doing Now, What the Future Holds, and How Tumor Profiling Is Just the Beginning | E Hall D1


CPO: Navigating Treatment Options in Advanced Neuroendocrine Tumors | E451b

Poster Highlights Session: Gastrointestinal (Noncolorectal) Cancer Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00AM, E354b | Discussion: 11:30 AM-12:45 PM, E Hall D2

Genitourinary Cancer Oral Abstract Session: Genitourinary (Prostate) Cancer | N Hall B1

CPO: Rare Genitourinary Tumors: Lethal Prostate Cancer Variants, Non-Clear Cell Renal Cell Carcinoma, and Penile Cancer | E451b

ED: Moving Forward in Advanced Prostate Cancer Clinical Development | E Hall D2

Geriatric Oncology

Gynecologic Cancer CSS: Finding the Targets in Gynecologic Cancers | E354aED: Quality and Value in Gynecologic Cancer Care: Do We Get What We Pay For? | E354a

ED: Ovarian and Cervix Avatars: The Key to Individualized Therapy? | E354a

Head and Neck CancerCPO: Toxicity Management in Head and Neck Cancer | E451b

CSS: Immunobiology and Immunotherapy | S100bc


ED: Overdiagnosis and Overtreatment in Cancer: Point/Counterpoint | E253

ED: The Present and Future of the State of the Art in Health Services Research | E253

ED: What We Can Learn from International Health Care Systems: Approaching Sustainable Cancer Care from a Global Perspective | E253

ED: The 2013 Institute of Medicine Report on Delivering Quality Cancer Care: What Needs to Happen | E354a


CPO: Therapeutic Advances in Myeloproliferative Neoplasms: Focus on Myelofibrosis and Chronic Myelogenous Leukemia | E451b

Lung Cancer

Poster Highlights Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers Display: 8:00 AM-11:00 AM, S405 | Networking with Experts: 10:00 AM-11:00AM, Between S405 and S406 | Discussion: 11:30 AM-12:45 PM, S406

ED: Understanding, Exploring, and Looking at New and Future Developments in Non-Small Cell Lung Cancer Immunotherapy | E Hall D1

ED: How to Talk with Your Pathologist about Molecular Testing | E Arie Crown Theater


MTP: Treatment of the Patient with High-Risk Myeloma | E451a

ED: Follow-up Imaging in Lymphoma: A Debate on Its Use | E Arie Crown Theater

Oral Abstract Session: Lymphoma | E Hall D2

Melanoma/Skin CancersCSS: Novel Combination Therapies for Melanoma | E Arie Crown Theater

MTP: Identification and Management of Systemic and Cutaneous Toxicities from Vemurafenib, Dabrafenib, Trametinib, and Ipilimumab for Melanoma | E451a


General Poster Session: Patient and Survivor Care | S Hall A

ED: Accelerated Aging among Cancer Survivors: From Pediatrics to Geriatrics | S404

MTP: Ask the Specialist: Cardiac Complications of Cancer Treatments | E451a

Pediatric OncologyED: Genetic Predisposition to Survival and Survivorship: How Far Are We from Individualized Therapy? | S504

Oral Abstract Session: Pediatric Oncology II | S504MTP: Nonrhabdomyosarcoma Soft Tissue Sarcomas in Children and Young Adults | E451a



ED: Training Program Directors’ Breakfast | S404ED: The Future Is Now: Incorporating Electronic Health Records, Web-Based Decision Tools, and Social Media into Your Clinical Practice | S504

Sarcoma Oral Abstract Session: Sarcoma | S406ED: Novel Molecular and Metabolic Targets in Sarcoma | S406

Tumor Biology




7:30 AM 8:00 9:00 10:00 11:00 12:00 PM 1:00 2:00 3:00 4:00 5:00

Special Sessions

Highlights of the Day I Session Including Clinical Trials Participation Awards | E Hall D1

Plenary Session Including the Science of Oncology Award and Lecture | N Hall B1Plenary Session Simulcast, E Hall D1

Post-Plenary Discussion I: Genitourinary Cancer | S100bc

Post-Plenary Discussion III: Breast Cancer | S100bc

ASCO–American Cancer Society Award and Lecture | S100a

Post-Plenary Discussion II: Gastrointestinal Cancer | S100a

Breast CancerPoster Highlights Session: Breast Cancer—HER2/ER Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00AM, E354b | Discussion: 11:30 AM-12:45 PM, E Arie Crown Theater

ED: Streamlining Breast Cancer Care: Opportunities and Challenges | N Hall B1

Cancer Genetics


General Poster Session: Cancer Prevention/Epidemiology | S Hall AED: Hype versus Hope: Repurposing Metformin, Vitamin D, Aspirin, Beta-Blockers, and Folic Acid for Cancer | S404


Oral Abstract Session: Central Nervous System Tumors | E450ED: Tools for the Best Outcomes in the Management of Brain Metastases | E450

ED: Immunotherapy: Transforming Frustration to Cure in the Next 50 Years | E450

Clinical TrialsED: Access to Data from Clinical Trials: A New Age of Clinical Trial Transparency | S100bc

ED: 50 Years of Precision Medicine: Advances in the Field and Prospective and Innovative Randomized Clinical Trials | S100bc

ED: Developing a Usable Biomarker: Odyssey of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma— From a Journal Report to a Multinational Clinical Trial | S100a


General Poster Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics | S Hall A

General Poster Session: Developmental Therapeutics— Immunotherapy | S Hall A

ED: Radiopharmaceuticals: Spanning Hematologic Malignancies to Solid Tumors | S100a

EthicsED: Eight Days a Week: Managing Cumulative Expectations for the Busy Oncology Provider | E253


ED: The Evolution of Our Molecular Understanding of Colorectal Cancer: What We Are Doing Now, What the Future Holds, and How Tumor Profiling Is Just the Beginning | E Hall D1


CPO: Navigating Treatment Options in Advanced Neuroendocrine Tumors | E451b

Poster Highlights Session: Gastrointestinal (Noncolorectal) Cancer Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00AM, E354b | Discussion: 11:30 AM-12:45 PM, E Hall D2

Genitourinary Cancer Oral Abstract Session: Genitourinary (Prostate) Cancer | N Hall B1

CPO: Rare Genitourinary Tumors: Lethal Prostate Cancer Variants, Non-Clear Cell Renal Cell Carcinoma, and Penile Cancer | E451b

ED: Moving Forward in Advanced Prostate Cancer Clinical Development | E Hall D2

Geriatric Oncology

Gynecologic Cancer CSS: Finding the Targets in Gynecologic Cancers | E354aED: Quality and Value in Gynecologic Cancer Care: Do We Get What We Pay For? | E354a

ED: Ovarian and Cervix Avatars: The Key to Individualized Therapy? | E354a

Head and Neck CancerCPO: Toxicity Management in Head and Neck Cancer | E451b

CSS: Immunobiology and Immunotherapy | S100bc


ED: Overdiagnosis and Overtreatment in Cancer: Point/Counterpoint | E253

ED: The Present and Future of the State of the Art in Health Services Research | E253

ED: What We Can Learn from International Health Care Systems: Approaching Sustainable Cancer Care from a Global Perspective | E253

ED: The 2013 Institute of Medicine Report on Delivering Quality Cancer Care: What Needs to Happen | E354a


CPO: Therapeutic Advances in Myeloproliferative Neoplasms: Focus on Myelofibrosis and Chronic Myelogenous Leukemia | E451b

Lung Cancer

Poster Highlights Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers Display: 8:00 AM-11:00 AM, S405 | Networking with Experts: 10:00 AM-11:00AM, Between S405 and S406 | Discussion: 11:30 AM-12:45 PM, S406

ED: Understanding, Exploring, and Looking at New and Future Developments in Non-Small Cell Lung Cancer Immunotherapy | E Hall D1

ED: How to Talk with Your Pathologist about Molecular Testing | E Arie Crown Theater


MTP: Treatment of the Patient with High-Risk Myeloma | E451a

ED: Follow-up Imaging in Lymphoma: A Debate on Its Use | E Arie Crown Theater

Oral Abstract Session: Lymphoma | E Hall D2

Melanoma/Skin CancersCSS: Novel Combination Therapies for Melanoma | E Arie Crown Theater

MTP: Identification and Management of Systemic and Cutaneous Toxicities from Vemurafenib, Dabrafenib, Trametinib, and Ipilimumab for Melanoma | E451a


General Poster Session: Patient and Survivor Care | S Hall A

ED: Accelerated Aging among Cancer Survivors: From Pediatrics to Geriatrics | S404

MTP: Ask the Specialist: Cardiac Complications of Cancer Treatments | E451a

Pediatric OncologyED: Genetic Predisposition to Survival and Survivorship: How Far Are We from Individualized Therapy? | S504

Oral Abstract Session: Pediatric Oncology II | S504MTP: Nonrhabdomyosarcoma Soft Tissue Sarcomas in Children and Young Adults | E451a



ED: Training Program Directors’ Breakfast | S404ED: The Future Is Now: Incorporating Electronic Health Records, Web-Based Decision Tools, and Social Media into Your Clinical Practice | S504

Sarcoma Oral Abstract Session: Sarcoma | S406ED: Novel Molecular and Metabolic Targets in Sarcoma | S406

Tumor Biology

Monday, June 2 CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session

7:30 AM 8:00 9:00 10:00 11:00 12:00 PM 1:00 2:00 3:00 4:00 5:00

Special Sessions

Highlights of the Day II Session Including Partners in Progress Award | E Hall D1

ASCO Annual Business Meeting (ASCO Members Only) | S100a

ASCO Book Club: Mountains Beyond Mountains | S103

ASCO/Radiological Society of North America (RSNA) Joint Session: Precision Imaging for Precision Medicine | S100bc

ASCO/European CanCer Organisation (ECCO) Joint Session: Value and Cancer Care | S100bc

Breast Cancer

General Poster Session: Breast Cancer—HER2/ER | S Hall A Poster Highlights Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy Display: 1:15 PM-4:15 PM, E354b | Networkng with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E Hall D1

General Poster Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy | S Hall A ED: A Brave New World: Contemporary Management of HER2-Positive Breast Cancer | N Hall B1

ED: Navigating a Changing Sea: Optimizing Treatment of Hormone Receptor–Positive Breast Cancer | N Hall B1

Cancer Genetics ED: Pharmacogenomics in the Era of Next-Generation Sequencing | S404

ED: Cancer Genomics and Inherited Risk: Recent Advances and Current Challenges | S404

ED: Hereditary Breast and Colon Cancer, and Clinical Oncology: Past, Present, and Future | S404

ED: Predisposition to Pediatric and Hematologic Cancers: A Moving Target | S404 ED: Second Cancers: Genomics and Detection | S404


CSS: Next-Generation Sequencing Panels for Cancer Risk Assessment | S100a

Poster Highlights Session: Cancer Prevention/Epidemiology Display: 1:15 PM-4:15 PM, S102 | Networkng with Experts: 3:15 PM-4:15 PM, Outside S101 | Discussion: 4:45 PM-6:00 PM, S100a

CPO: Breast Density: Clinical Impact and Emerging Legal Issues | E451b


ED: Medulloblastoma: Modern Molecular Diagnostics and Clinical Decision Making | E253

Clinical Trials ED: Internet, Social Media, Privacy Regulations, and Clinical Trials | S504


Poster Highlights Session: Developmental Therapeutics— Immunotherapy Display: 1:15 PM-4:15 PM, S405 | Networkng with Experts: 3:15 PM-4:15 PM, Between S405 and S406 | Discussion: 4:45 PM-6:00 PM, S406

ED: Cancer Nanotechnology: Path to New Diagnostics and Therapeutics | S100bc

Ethics

Gastrointestinal (Colorectal) Cancer Oral Abstract Session: Gastrointestinal (Colorectal) Cancer | E Arie Crown Theater


ED: Rare but Real: Management of Pseudomyxoma Peritonei, Gallbladder Cancer, and Periampullary Cancers | N Hall B1

Oral Abstract Session: Gastrointestinal (Noncolorectal) Cancer | E Hall D1ED: The Past, Present, and Future of Noncolorectal Gastrointestinal Cancers: Have We Moved the Bar? | N Hall B1

MTP: Management of Hepatocellular Cancer: Right Patient, Right Treatment, Right Time | E451a


ED: Renal Cell Carcinoma from Small Renal Masses to Advanced Disease | E Hall D2 Oral Abstract Session: Genitourinary (Nonprostate) Cancer | E Hall D1 General Poster Session: Genitourinary (Nonprostate) Cancer | S Hall A

General Poster Session: Genitourinary (Prostate) Cancer | S Hall A

ED: From Genetics to Geriatric Medicine in Bladder Cancer | E Hall D2

Geriatric Oncology

Gynecologic Cancer Poster Highlights Session: Gynecologic Cancer Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00 AM, E354b | Discussion: 11:30 AM-12:45 PM, E354a

ED: Survivorship in Gynecologic Cancer: Enduring the Treatment, Surviving the Cure | E354a

ED: Rare Gynecologic Tumors: New Targets, New Therapies | E354a


Oral Abstract Session: Head and Neck Cancer | E450 Poster Highlights Session: Head and Neck Cancer Display: 1:15 PM-4:15 PM, E354b | Networkng with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E450

ED: Migration from Carcinogen to Virus: 50 Years of Evolution in Epidemiology and Treatment of Head and Neck Cancer | E450

Health Services ResearchOral Abstract Session: Health Services Research | E253 General Poster Session: Health Services Research | S Hall A2

ED: The Winds of Change: Cancer Disparities in the Health Care Reform Era | E253


CPO: Raising the Bar: Moving toward Improved Outcomes in Myelodysplastic Syndromes | E451b General Poster Session: Leukemia, Myelodysplasia, and Transplantation | S Hall A

ED: Chronic Lymphocytic Leukemia Therapy: An Update on Frontline and Novel Therapies | E450

Lung Cancer CPO: Multimodality Management of Non-Small Cell Lung Cancer: Curative and Palliative Care | E451b Oral Abstract Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers | E Hall D2

ED: Time to Look Again: Emerging Biology and Therapeutics in Small Cell and Large Cell Neuroendocrine Cancers, Thymoma/Thymic Carcinomas, and Mesothelioma | E Arie Crown Theater

Oral Abstract Session: Lung Cancer—Non-Small Cell Metastatic | E Hall D2


Oral Abstract Session: Myeloma | E354a

CPO: Clinical Conundrums in Lymphoid Malignancies: Uncommon Problems in Common Diseases and Common Problems in Uncommon Diseases | E451b

General Poster Session: Lymphoma and Plasma Cell Disorders | S Hall A

ED: Lymphoma and Myeloma: Where We Were, Where We Are, Where We Are Going | S100a

Melanoma/Skin Cancers Poster Highlights Session: Melanoma/Skin Cancers Display: 8:00 AM-12:00 PM, E354b | Networking with Experts: 10:00 AM-12:00 PM, E354b | Discussion: 11:30 AM-12:45 PM, E Arie Crown Theater Oral Abstract Session: Melanoma/Skin Cancers | E Arie Crown Theater


Poster Highlights Session: Patient and Survivor Care Display: 8:00 AM-11:00 AM, S102 | Networking with Experts: 10:00 AM-11:00 AM, Outside S101 | Discussion: 11:30 AM-12:45 PM, S100b Oral Abstract Session: Patient and Survivor Care | E253

ED: Cancer Survivorship Programs Across Different Health Care Settings: Past, Present, and Future | S504

Pediatric OncologyPoster Highlights Session: Pediatric Oncology Display: 8:00 AM-11:00 AM, S Hall A | Networking with Experts: 10:00 AM-11:00 AM, S Hall A | Discussion: 11:30 AM-12:45 PM, S504

CPO: Clinical Research in Children with Cancer: Challenges and Opportunities | E451b

ED: Beyond Stage and Anaplasia: New Approaches to Risk Stratification for Wilms Tumor | S504

ED: 50 Years of Pediatric Oncology: From Chemotherapy to Genomics to Targeted Therapy | S504

General Poster Session: Pediatric Oncology | S Hall A


MTP: How to Smartly Use Smartphones, Twitter, and Social Media to Efficiently Enhance Clinical Practice | E451a


ED: Tumor Boards: Optimizing the Structure and Improving Efficiency of Multidisciplinary Treatment of Patients with Cancer Worldwide | S504

ED: MOC 101: Orientation to MOC Requirements | E354a

MTP: Tips for Successful Contract Negotiation | E451a

SarcomaGeneral Poster Session: Sarcoma | S Hall A CSS: Exploring the Spectrum of Sarcoma Genome | S406 CPO: Successes in Gastrointestinal Stromal Tumors:

Long-term Considerations and Survivorship | E451b

ED: Golden Jubilee: 50 Years of Advances in Sarcoma | S406

MTP: The Management of Intra-abdominal Sarcomas | E451a

Tumor Biology

Poster Highlights Session: Tumor Biology Display: 8:00 AM-11:00 AM, S405 | Networking with Experts: 10:00 AM-11:00 AM, Between S405 and S406 | Discussion: 11:30 AM-12:45 PM, S406

MTP: From Immunotherapy Research to Clinical Vaccines | E451a Oral Abstract Session: Tumor Biology | S100bc

ED: In Vivo Preclinical Models: Making Inroads into Personalized Therapy | S406




7:30 AM 8:00 9:00 10:00 11:00 12:00 PM 1:00 2:00 3:00 4:00 5:00

Special Sessions

Highlights of the Day II Session Including Partners in Progress Award | E Hall D1

ASCO Annual Business Meeting (ASCO Members Only) | S100a

ASCO Book Club: Mountains Beyond Mountains | S103

ASCO/Radiological Society of North America (RSNA) Joint Session: Precision Imaging for Precision Medicine | S100bc

ASCO/European CanCer Organisation (ECCO) Joint Session: Value and Cancer Care | S100bc

Breast Cancer

General Poster Session: Breast Cancer—HER2/ER | S Hall A Poster Highlights Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy Display: 1:15 PM-4:15 PM, E354b | Networkng with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E Hall D1

General Poster Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy | S Hall A ED: A Brave New World: Contemporary Management of HER2-Positive Breast Cancer | N Hall B1

ED: Navigating a Changing Sea: Optimizing Treatment of Hormone Receptor–Positive Breast Cancer | N Hall B1

Cancer Genetics ED: Pharmacogenomics in the Era of Next-Generation Sequencing | S404

ED: Cancer Genomics and Inherited Risk: Recent Advances and Current Challenges | S404

ED: Hereditary Breast and Colon Cancer, and Clinical Oncology: Past, Present, and Future | S404

ED: Predisposition to Pediatric and Hematologic Cancers: A Moving Target | S404 ED: Second Cancers: Genomics and Detection | S404


CSS: Next-Generation Sequencing Panels for Cancer Risk Assessment | S100a

Poster Highlights Session: Cancer Prevention/Epidemiology Display: 1:15 PM-4:15 PM, S102 | Networkng with Experts: 3:15 PM-4:15 PM, Outside S101 | Discussion: 4:45 PM-6:00 PM, S100a

CPO: Breast Density: Clinical Impact and Emerging Legal Issues | E451b


ED: Medulloblastoma: Modern Molecular Diagnostics and Clinical Decision Making | E253

Clinical Trials ED: Internet, Social Media, Privacy Regulations, and Clinical Trials | S504


Poster Highlights Session: Developmental Therapeutics— Immunotherapy Display: 1:15 PM-4:15 PM, S405 | Networkng with Experts: 3:15 PM-4:15 PM, Between S405 and S406 | Discussion: 4:45 PM-6:00 PM, S406

ED: Cancer Nanotechnology: Path to New Diagnostics and Therapeutics | S100bc

Ethics

Gastrointestinal (Colorectal) Cancer Oral Abstract Session: Gastrointestinal (Colorectal) Cancer | E Arie Crown Theater


ED: Rare but Real: Management of Pseudomyxoma Peritonei, Gallbladder Cancer, and Periampullary Cancers | N Hall B1

Oral Abstract Session: Gastrointestinal (Noncolorectal) Cancer | E Hall D1ED: The Past, Present, and Future of Noncolorectal Gastrointestinal Cancers: Have We Moved the Bar? | N Hall B1

MTP: Management of Hepatocellular Cancer: Right Patient, Right Treatment, Right Time | E451a


ED: Renal Cell Carcinoma from Small Renal Masses to Advanced Disease | E Hall D2 Oral Abstract Session: Genitourinary (Nonprostate) Cancer | E Hall D1 General Poster Session: Genitourinary (Nonprostate) Cancer | S Hall A

General Poster Session: Genitourinary (Prostate) Cancer | S Hall A

ED: From Genetics to Geriatric Medicine in Bladder Cancer | E Hall D2

Geriatric Oncology

Gynecologic Cancer Poster Highlights Session: Gynecologic Cancer Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00 AM, E354b | Discussion: 11:30 AM-12:45 PM, E354a

ED: Survivorship in Gynecologic Cancer: Enduring the Treatment, Surviving the Cure | E354a

ED: Rare Gynecologic Tumors: New Targets, New Therapies | E354a


Oral Abstract Session: Head and Neck Cancer | E450 Poster Highlights Session: Head and Neck Cancer Display: 1:15 PM-4:15 PM, E354b | Networkng with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E450

ED: Migration from Carcinogen to Virus: 50 Years of Evolution in Epidemiology and Treatment of Head and Neck Cancer | E450

Health Services ResearchOral Abstract Session: Health Services Research | E253 General Poster Session: Health Services Research | S Hall A2

ED: The Winds of Change: Cancer Disparities in the Health Care Reform Era | E253


CPO: Raising the Bar: Moving toward Improved Outcomes in Myelodysplastic Syndromes | E451b General Poster Session: Leukemia, Myelodysplasia, and Transplantation | S Hall A

ED: Chronic Lymphocytic Leukemia Therapy: An Update on Frontline and Novel Therapies | E450

Lung Cancer CPO: Multimodality Management of Non-Small Cell Lung Cancer: Curative and Palliative Care | E451b Oral Abstract Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers | E Hall D2

ED: Time to Look Again: Emerging Biology and Therapeutics in Small Cell and Large Cell Neuroendocrine Cancers, Thymoma/Thymic Carcinomas, and Mesothelioma | E Arie Crown Theater

Oral Abstract Session: Lung Cancer—Non-Small Cell Metastatic | E Hall D2


Oral Abstract Session: Myeloma | E354a

CPO: Clinical Conundrums in Lymphoid Malignancies: Uncommon Problems in Common Diseases and Common Problems in Uncommon Diseases | E451b

General Poster Session: Lymphoma and Plasma Cell Disorders | S Hall A

ED: Lymphoma and Myeloma: Where We Were, Where We Are, Where We Are Going | S100a

Melanoma/Skin Cancers Poster Highlights Session: Melanoma/Skin Cancers Display: 8:00 AM-12:00 PM, E354b | Networking with Experts: 10:00 AM-12:00 PM, E354b | Discussion: 11:30 AM-12:45 PM, E Arie Crown Theater Oral Abstract Session: Melanoma/Skin Cancers | E Arie Crown Theater


Poster Highlights Session: Patient and Survivor Care Display: 8:00 AM-11:00 AM, S102 | Networking with Experts: 10:00 AM-11:00 AM, Outside S101 | Discussion: 11:30 AM-12:45 PM, S100b Oral Abstract Session: Patient and Survivor Care | E253

ED: Cancer Survivorship Programs Across Different Health Care Settings: Past, Present, and Future | S504

Pediatric OncologyPoster Highlights Session: Pediatric Oncology Display: 8:00 AM-11:00 AM, S Hall A | Networking with Experts: 10:00 AM-11:00 AM, S Hall A | Discussion: 11:30 AM-12:45 PM, S504

CPO: Clinical Research in Children with Cancer: Challenges and Opportunities | E451b

ED: Beyond Stage and Anaplasia: New Approaches to Risk Stratification for Wilms Tumor | S504

ED: 50 Years of Pediatric Oncology: From Chemotherapy to Genomics to Targeted Therapy | S504

General Poster Session: Pediatric Oncology | S Hall A


MTP: How to Smartly Use Smartphones, Twitter, and Social Media to Efficiently Enhance Clinical Practice | E451a


ED: Tumor Boards: Optimizing the Structure and Improving Efficiency of Multidisciplinary Treatment of Patients with Cancer Worldwide | S504

ED: MOC 101: Orientation to MOC Requirements | E354a

MTP: Tips for Successful Contract Negotiation | E451a

SarcomaGeneral Poster Session: Sarcoma | S Hall A CSS: Exploring the Spectrum of Sarcoma Genome | S406 CPO: Successes in Gastrointestinal Stromal Tumors:

Long-term Considerations and Survivorship | E451b

ED: Golden Jubilee: 50 Years of Advances in Sarcoma | S406

MTP: The Management of Intra-abdominal Sarcomas | E451a

Tumor Biology

Poster Highlights Session: Tumor Biology Display: 8:00 AM-11:00 AM, S405 | Networking with Experts: 10:00 AM-11:00 AM, Between S405 and S406 | Discussion: 11:30 AM-12:45 PM, S406

MTP: From Immunotherapy Research to Clinical Vaccines | E451a Oral Abstract Session: Tumor Biology | S100bc

ED: In Vivo Preclinical Models: Making Inroads into Personalized Therapy | S406

Tuesday, June 3CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session SPS = Special Session

MTP = Meet the Professor Session (ticketed) CPO = Clinical Problems in Oncology Session (ticketed) = 50th Anniversary Session

7:30 AM 8:00 9:00 10:00 11:00 12:00 PM

Special Sessions Highlights of the Day III Session | E Hall D1

Breast CancerED: Targeting and Tailoring Therapy for Triple-Negative Breast Cancer | S406

Oral Abstract Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy | E Hall D1

Cancer GeneticsCancer Prevention/EpidemiologyCentral Nervous System TumorsClinical Trials


ED: Innovative Strategies for Picking Combination Therapy Regimens | S100a

Oral Abstract Session: Developmental Therapeutics—Immunotherapy | S100a

EthicsGastrointestinal (Colorectal) Cancer

CSS: Colorectal Cancer: Not Just One Disease | S406


ED: Pancreatic Cancer: Selecting Initial Treatment Strategies | E354a


ED: 50 Years of Progress in Advanced Prostate Cancer | S100bc

Geriatric OncologyGynecologic CancerHead and Neck Cancer


ED: Incorporating the Patient’s Voice: Patient Engagement in Research | E253Poster Highlights Session: Health Services Research Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00 AM, E354b | Discussion: 11:30 AM-12:45 PM, E253


Oral Abstract Session: Leukemia, Myelodysplasia, and Transplantation | E354a

Lung Cancer

Poster Highlights Session: Lung Cancer—Non-Small Cell Metastatic Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00 AM, E354b | Discussion: 11:30 AM-12:45 PM, E450

ED: Why Is Chemotherapy Here to Stay in Lung Cancer? | E450


Melanoma/Skin Cancers

ED: Biology of Basal Cell, Squamous Cell, and Merkel Cell Carcinomas: Implications for Management | E450


ED: Interacting with Family Members of a Patient: Oncologist Perspectives Based on Personal Experiences | S100bc

CSS: Palliative Care: Interventions That Matter | E253

Pediatric OncologyPractice Management and Information TechnologyProfessional Development

Sarcoma Poster Highlights Session: Sarcoma Display: 8:00 AM-11:00 AM, S102 | Networking with Experts: 10:00 AM-11:00 AM, Outside S101 | Discussion: 11:30 AM-12:45 PM, S100bc

Tumor Biology ED: Proteomics: Ready for Clinical Translation? | S404

sessions at a glance - cmt.com.cnpic1.cmt.com.cn/newspic/files/am14-grids-8x10-final.pdf ·...

Documents